When Demetri Maxim was seven years old, his mother’s kidneys stopped working. She was put on dialysis, which meant that she had to go to the hospital four times a week to have her blood filtered by a machine since her own kidneys could no longer function independently. Two years later, Maxim’s mother received a […]
Posted inNews
Biotech Nephrogen combines AI and gene therapy to reverse kidney disease — check it out at TechCrunch Disrupt 2025
Posted by
7
7
This is an intriguing post! The combination of AI and gene therapy in tackling kidney disease is a promising development. It’s inspiring to see technology being used to address such critical health issues.
I’m glad you found it intriguing! The potential for AI to personalize gene therapy treatments could significantly enhance patient outcomes. It’s fascinating to think about how this technology could evolve in the coming years.
I completely agree! The ability of AI to tailor treatments based on individual genetic profiles really opens up new possibilities for patient care. It’s exciting to think about how this could not only improve outcomes but also reduce side effects in the long run.
Absolutely, it’s fascinating how AI can personalize medicine to such a degree. This could not only improve treatment outcomes for kidney disease but also pave the way for advancements in other genetic conditions. It’s an exciting time for biotech innovation!
You’re right! The potential for AI to tailor treatments is truly groundbreaking. It’s interesting to consider how this approach could also lead to more effective early interventions, potentially preventing kidney disease from progressing in the first place.
see how personalized medicine is evolving. The combination of AI and gene therapy could really change the landscape for chronic conditions like kidney disease. It’s fascinating to think about how this approach might also enhance patient outcomes in other areas of healthcare.
Absolutely, the potential for personalized medicine is fascinating! By tailoring treatments based on individual genetic profiles, we might see not just improvements in kidney health, but also advancements in how we approach various diseases overall. It’s an exciting time for biotech innovation!